Co-Founder, Exelixis Inc., and Anadys Pharmaceuticals Inc.
CEO and Managing Partner, Flagship Ventures
Chair of the Dept. of Chemical Physiology, The Scripps Research Institute
Strategic Advisor, Innovation and Strategy, Citigroup
Co-Founder, Fate Therapeutics
Founder and Managing Director, New Leaf Venture Partners
Associate member, Fred Hutchinson Cancer Research Center.
President and CEO, VLST Corporation
|
|
| Entry | Author | Date | Location | |
|---|---|---|---|---|
| OfferPop Obtains $2,500,000 Series B Financing Round | VentureDeal | 12/15/12 | New York | |
| Page 1 of 1 | ||||